These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3362383)

  • 21. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
    Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
    Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of malignant hyperthermia contractures in Becker-Duchenne dystrophy at age 2.
    Gronert GA; Fowler W; Cardinet GH; Grix A; Ellis WG; Schwartz MZ
    Muscle Nerve; 1992 Jan; 15(1):52-6. PubMed ID: 1732762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. King-Denborough syndrome: contracture testing and literature review.
    Heiman-Patterson TD; Rosenberg HR; Binning CP; Tahmoush AJ
    Pediatr Neurol; 1986; 2(3):175-7. PubMed ID: 2907859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant hyperthermia or myotonia congenita].
    Amores Lloret A; Martínez Hernández A
    Rev Esp Anestesiol Reanim; 1988; 35(6):346. PubMed ID: 3238135
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postoperative hyperthermic syndrome with a questionable relationship to malignant hyperthermia and the need for elucidating susceptibility].
    Plötz J
    Anaesthesist; 1986 Dec; 35(12):751-4. PubMed ID: 3826611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Masseter spasm and malignant hyperthermia: a retrospective review of a hospital-based pediatric otolaryngology practice.
    Kosko JR; Brandom BW; Chan KH
    Int J Pediatr Otorhinolaryngol; 1992 Jan; 23(1):45-50. PubMed ID: 1592551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant hyperthermia susceptibility without central core disease (CCD) in a family where CCD is diagnosed.
    Islander G; Henriksson KG; Ranklev-Twetman E
    Neuromuscul Disord; 1995 Mar; 5(2):125-7. PubMed ID: 7767091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal muscle spindle morphology in myotonia congenita: the spindle abnormality in myotonic dystrophy is not due to myotonia alone.
    Swash M; Schwartz MS
    Clin Neuropathol; 1983; 2(2):75-8. PubMed ID: 6221849
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignant hyperthermia in a patient with sickle cell anemia.
    Gürgey A; Altay C; Ozgen S
    Turk J Pediatr; 1989; 31(3):245-7. PubMed ID: 2485991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant Hyperthermia Susceptibility and Fitness for Duty.
    Lee MA; McGlinch EB; McGlinch MC; Capacchione JF
    Mil Med; 2017 Mar; 182(3):e1854-e1857. PubMed ID: 28290972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halothane-sensitivity gene and muscle contractile properties in malignant hyperthermia.
    Gallant EM; Mickelson JR; Roggow BD; Donaldson SK; Louis CF; Rempel WE
    Am J Physiol; 1989 Oct; 257(4 Pt 1):C781-6. PubMed ID: 2801926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant hyperpyrexia and sudden infant death syndrome.
    Ellis FR; Halsall PJ; Harriman DG
    Br J Anaesth; 1988 Jan; 60(1):28-30. PubMed ID: 3337790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility.
    Zaharieva IT; Sarkozy A; Munot P; Manzur A; O'Grady G; Rendu J; Malfatti E; Amthor H; Servais L; Urtizberea JA; Neto OA; Zanoteli E; Donkervoort S; Taylor J; Dixon J; Poke G; Foley AR; Holmes C; Williams G; Holder M; Yum S; Medne L; Quijano-Roy S; Romero NB; Fauré J; Feng L; Bastaki L; Davis MR; Phadke R; Sewry CA; Bönnemann CG; Jungbluth H; Bachmann C; Treves S; Muntoni F
    Hum Mutat; 2018 Dec; 39(12):1980-1994. PubMed ID: 30168660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porcine malignant hyperthermia: false negatives in the halothane test.
    Gallant EM; Rempel WE
    Am J Vet Res; 1987 Mar; 48(3):488-91. PubMed ID: 3565905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anesthesia-induced rigidity, unrelated to succinylcholine, associated with Smith-Lemli-Opitz syndrome and malignant hyperthermia.
    Petersen WC; Crouch ER
    Anesth Analg; 1995 Mar; 80(3):606-8. PubMed ID: 7864433
    [No Abstract]   [Full Text] [Related]  

  • 39. Muscular body build and male sex are independently associated with malignant hyperthermia susceptibility.
    Butala B; Brandom B
    Can J Anaesth; 2017 Apr; 64(4):396-401. PubMed ID: 28063098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant hyperthermia: update on susceptibility testing.
    Litman RS; Rosenberg H
    JAMA; 2005 Jun; 293(23):2918-24. PubMed ID: 15956637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.